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Abstract
Thiol containing NO fl-derivatives were found to inhibit the activity of brain and kidney NarK-ATPase. S-Nitrosoglutha-
 .tione demonstrated only minor inhibiting activity, while dinitrosyl iron complexes DNIC with cysteine or glutathione were
much more effective. Brain NarK-ATPase is more vulnerable to inhibiting action than kidney NarK-ATPase. Inhibition of
the activity is accompanied by a decrease in amount of protein thiol groups and a change in the substrate dependence curve
of the enzyme. Restoration of NarK-ATPase activity by SH-reagent dithiothreitol or cysteine is accompanied by restoration
of SH-groups of the enzyme. This suggests that blockade of SH-groups of NarK-ATPase is responsible for the inhibition.
The possibility that this blockade results in disordering of interprotomer interactions within the oligomeric complexes of
NarK-ATPase is suggested. Possible regulatory meaning of the effect of NO fl derivatives is discussed. q 1997 Elsevier
Science B.V.
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1. Introduction
NO-radical is known to play diverse important
roles as second messenger in biological systems,
regulator of haem containing enzymes like guanylate
w xcyclase, or inductor of ADP-ribosylation 1,2 . Some
investigators reported that NO fl can modify oxidative
Abbreviations: DNIC-CYS, dinitrosyl iron complexes with
cysteine; DNIC-GS, dinitrosyl iron complexes with glutathione;
 .DTT, dithiothreitol; DTNB, 5,5-dithio-bis 2-nitrobenzoic acid;
EPR, electron paramagnetic resonance; GS-NO, S-nitrosoglutath-
X ione; NO, nitric oxide; PIPES, piperasine-N, N -bis 2-ethane-
.sulfonic acid ; SNP, sodium nitroprusside
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processes in the cell demonstrating both pro- and
w xanti-oxidant properties 2,3 .
Recently additional functions of NO radical were
described — an ability to open K-channels in the
plasma membrane of vascular smooth muscle cells
w x4 and to inactivate NMDA receptors in various
w x flareas of brain 5 . In both cases the NO effect was
found to be realized via reversible oxidation of SH-
groups of channel proteins, and such mechanism
presumably involves S-nitrosylation of protein
w xresidues 4 .
These data attract an attention to NarK-ATPase
 .E.C. 3.6.1.37 , — an enzyme system which supports
ionic homeostasis in the cell. Indirect effect of NO fl
on this enzyme mediated by activation of NarH-ex-
w x w xchanger 6 or protein kinase C 7 were recently
0005-2728r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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published using tissues slices, but sensitivity of
NarK-ATPase itself to NO radical was not character-
w xized. Very recently Sato et al 8 have reported
inhibition of pig brain NarK-ATPase by NO fl gener-
ating drugs. However no direct effect of NO fl on
w xkidney NarK-ATPase was observed 9 . NarK-
ATPase is known to be an SH containing enzyme
w x10 . Its thiol groups could be the target not only for
NO fl but also for its stable compounds which are
w xdescribed in living cells, namely S-nitrosothiols 11
 .or dinitrosyl iron complexes DNIC with thiol con-
w xtaining compounds 12 . This suggestion was exam-
ined in our experiments here.
2. Materials and methods
2.1. Reagents
ATP, ouabain, Tris-HCl, PIPES and sodium nitro-
 .  .prusside SNP were purchased from Sigma USA ,
 .other reagents were from Reachim Russia of analyt-
ical grade.
Dinitrosyl-iron complexes with cysteine DNIC-
.  .CYS or glutathione DNIC-GS and S-nitrosoglu-
 .tathione GS-NO were synthesized as described else-
w xwhere 13,14 . Two forms of DNIC were used in the
 .  .experiments: diamagnetic dimeric — DNIC 1:2 or
 .  .paramagnetic monomeric — DNIC 1:30 being
prepared at two different Fe2q ions to the thiol molar
 .ratio 1:2 and 1:30, respectively . Concentration of
the nitroso compounds used was controlled spec-
w xtrophotometrically or by the EPR method 13,14 .
2.2. Enzyme source
In the experiments partially purified membrane
bound NarK-ATPase from two different sources —
w x w xbovine brain 15 and dog kidney 16 was used.
2.3. Measurement of enzyme acti˝ity
NarK-ATPase activity was measured by inorganic
phosphate liberation as described by Rathbun and
w xBetlach 17 . Reaction medium for activity determina-
tion contained: 3 mM ATP, 5 mM MgCl , 130 mM2
 .NaCl, 20 mM KCl, and 30 mM PIPES pH 7.4 at 25
 .or 378C as noted in figure legends and tables in 1
ml volume; protein amount was 2–7 mg. NarK-
ATPase activity was calculated as a difference in Pi
liberation between these samples and anothers, con-
taining 1 mM ouabain, specific inhibitor of NarK-
ATPase. Reaction was stopped by addition of 3 M
 . sodium acetate pH 4.3 . Enzyme activity measured
.under optimal conditions at 378C was 170–220 mmol
P rmg per h for brain enzymes and 850–1000 mmoli
P rmg per h for kidney enzymes.i
2.4. Protein determination
Protein was determined according to Lowry et al.
w x18 after solubilization of membrane suspension in
1% sodium deoxycholate, with bovine serum albumin
as standard.
2.5. Assay of SH-groups of NarK-ATPase
The amount of SH-groups in NarK-ATPase
X preparations was determined using 5,5 -dithio bis- 2-
. w xnitrobenzoic acid , DTNB 19,20 . Absorbance of the
coloured product of the reaction was measured at 412
nm on a Hitachi-557 spectrophotometer. Aliquots of
60–100 mg of protein were added to medium con-
 .taining 1.0 mM EDTA, 10 mM Tris-HCl pH 8.0 , 8
M urea and 0.5% Tritone X-100. In the experiments
with low-molecular weight nitrosothiols the samples
after preincubation were placed on gel filtrating Ep-
 . pendorf tubes 1.3 ml and centrifuged 1000 g for 3
.min . The Eppendorf tubes were filled up with
Sephadex G-25 suspended in 10 mM Tris-HCl pH
.8.0 . This procedure prevented interaction of low-
molecular weight thiols with DTNB. In the special
experiments there was found that single gel filtration
procedure provides for a total removal of low-molec-
ular weight thiols from the sample.
2.6. Chemical modification of NarK-ATPase
The procedure of NO fl generation induced by SNP
w xillumination was described elsewhere 21 . The rate
of nitric oxide generation was determined by the
simultaneous spectrophotometric measurement of
ascorbic acid oxidation under the same conditions
 . w xascorbic acid test 9 .
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In order to modify NarK-ATPase by GS-NO or
DNICs the following procedure was used. ATPase
protein was preincubated 1.5–40 min at 48C with
different concentrations of inhibitors reaction was
started by the addition of inhibitor to preincubation
medium containing 150 mM KCl, 30 mM PIPES, pH
7.4, 1 mM EDTA and 0.2–1.3 mgrml NarK-
.ATPase . At the end of the exposure, aliquots of the
preincubation medium containing appropriate amount
of protein were taken up to assay ATPase activity
and content of SH-groups, as described above.
3. Results
3.1. Estimation of a direct effect of NO fl on NarK-
ATPase
In order to investigate the effect of NO fl on
NarK-ATPase, 1–10 mM SNP was added to the
preincubation medium. SNP is known to be a poor
source of the radical, but illumination strongly acti-
fl w xvates NO liberation 21 . However, using different
illumination conditions and a broad range of SNP
concentrations we found no difference in NarK-
ATPase activity with or without illumination of sam-
 .ples Table 1 . Thus, we conclude that under all of
the conditions used there was no direct inhibition of
NarK-ATPase by the NO radical. Modest suppres-
sion of the activity in the presence of SNP itself was
independent of illumination time and therefore was
ascribed to an effect on the enzyme of SNP itself.
Table 1
 .Effect of SNP on NarK-ATPase from bovine brain A or dog
 . kidney B under different conditions average results from three
.experiments and standard deviations are given
Preincubation conditions Illumination NarK-ATPase
 .% to control
Aq1 mM SNP 30 min, 48C y 86"5
q 89"5
Aq1 mM SNP 30 min, 208C y 77"4
q 77"3
Aq10 mM SNP 5 min, 208C y 75"5
q 77"4
Bq10 mM SNP 5 min, 208C y 70"5
q 63"4
Fig. 1. Dependence of bovine brain NarK-ATPase on concentra-
tion of NO complexes with glutathione and cysteine. Enzyme 25
.  .mgrml was preincubated 15 min at 48C with no additions 1 or
 .  .  .in the presence of GS-NO 2 , DNIC-GS 1:2 3 , or DNIC-CYS
 .  .1:2 4 . The preincubation medium consisted of 150 mM KCl,
 .30 mM PIPES pH 7.4 , 1 mM EDTA. After that samples of 25
ml volume were 40-fold diluted by incubation medium and use to
measure enzyme activity. NarK-ATPase activity was measured
at 378C in a medium containing 3 mM ATP, 5 mM MgCl , 1302
 .mM NaCl, 20 mM KCl, 30 mM PIPES pH 7.4 .
w x flIt is known from the literature 2 that NO genera-
tion in brain neurons being under stress conditions
amounts to 100 nmol per mg protein per h. In our
experiments we have followed NO fl generation by the
ascorbic acid test in parallel samples. The highest rate
of NO fl generation which we measured in the sam-
ples was to 300 nmolrh, whereas content of brain
NarK-ATPase in these samples was at least 20 times
w xhigher than that in brain homogenate 15 . However,
even under these conditions, inhibition of enzyme
activity was not found. Using in such experiment
kidney enzyme which is characterized by a higher
w xNarK-ATPase content 15,16 we also did not find
any direct effect of NO fl on NarK-ATPase activity.
3.2. Effects of NO fl containing compounds on Nar
K-ATPase
GS-NO and diamagnetic forms of DNIC-GS or
DNIC-CYS demonstrated inhibiting effects on the
 .enzyme being distinct in their efficiency Fig. 1 .
GS-NO revealed the lowest action, e.g., 100 mM
GS-NO suppressed enzyme activity by 12%, whereas
50 mM DNIC-GS or DNIC-CYS provided for 45%
and 70% inhibition of NarK-ATPase, respectively.
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Fig. 2. Dependence of brain NarK-ATPase modified by dimeric
DNIC complexes on NarK ratio in the incubation medium.
 .Enzyme 25 mgrml was preincubated 15 min at 48C with no
 .  .additions 1 as well as in the presence of 100 mM DNIC-GS 2 ,
 .  .42 mM 3 , or 105 mM 4 DNIC-CYS. Conditions of incubation
as in Fig. 1.
One of the features of the enzyme studied is its
specific dependence on the NarK ratio in the incuba-
tion medium. It is seen from Fig. 2 that inhibition of
NarK-ATPase by these DNIC’s was not accompa-
nied with a change in profile of such dependence,
thus demonstrating that a change in NarK-ratio did
not affect the action of the inhibitors. It is noteworthy
that inhibition of NarK-ATPase by H O and2 2
hypochlorous anion likewise was not protected by
w xsodium or potassium ions 22 .
Fig. 3 characterizes the inhibiting effect of dia-
magnetic DNIC-CYS on the enzyme; the effect does
depend on both concentration of the inhibitor and
time of preincubation. The lowest concentration of
the inhibitor needs 20 min for realization of the
whole effect, while the highest one takes it for less
than 1 min. Similar dependence was found for dia-
magnetic DNIC-GS.
3.3. Effect on SH-groups of the enzyme
We have compared sensitivity of the enzyme from
brain and kidney to inhibiting action of diamagnetic
Fig. 3. Time-course of inactivation of dog kidney NarK-ATPase
 .  .by DNIC-CYS 1:2 . NarK-ATPase 300 mgrml was preincu-
 .  .bated 2–40 min at 48C in the absence 1 or presence of 30 2 ,
 .  .60 3 or 100 4 mM DNIC-CYS, then activity was measured as
described in Materials and methods.
DNIC-CYS. It was found that brain enzyme is more
 .sensitive to inhibition than kidney enzyme Fig. 4 .
This agrees with the different sensitivities of these
enzymes to hydrogen peroxide and hypochlorous an-
w xion reported earlier 22 — NarK-ATPase from brain
is more vulnerable to oxidative modification than that
from kidney, independent of the chemistry of the
w xmodifying molecule 23 . This presumably corre-
sponds to a difference in the amount of SH-groups in
Fig. 4. Inhibiting effect of DNIC-CYS on NarK-ATPase from
 .  . dog kidney 1 and bovine brain 2 . Enzyme from brain 25
.  .mgrml and kidney 30 mgrml was preincubated 15 min with
 .different concentrations of DNIC-CYS 0–105 mM in the pres-
 .ence of 150 mM KCl, 30 mM PIPES pH 7.4 at 48C and 1 mM
EDTA.
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Fig. 5. Time-course of inhibition of NarK-ATPase activity black
.  .bars and thiol content grey bars in kidney enzyme preparation
 .during its modification by 50 mM DNIC-CYS 1:2 . NarK-
 .ATPase 1.0 mgrml was preincubated with DNIC-CYS as
described in Fig. 1. Sulfhydryl groups were determined as de-
scribed in Section 2. Decrease in both parameters comparatively
 .to control is statisticaly significant P -0.05 .
different isoforms of NarK-ATPase characteristic for
brain and kidney tissues: brain isoforms contain more
w xcysteine residues than the kidney isoform 24 .
In kidney NarK-ATPase 46 nmolrmg protein
SH-groups accessible to DTNB was found. This is in
a good correlation with an amount of NarK-ATPase
thiols in membrane preparations used: 20–23 mol per
w xmol NarK-ATPase of such a purity 15,16,25 . Actu-
ally, inhibition of the enzyme by oxidants is known
to result in simultaneous decrease in DTNB titratable
w xSH-groups 20,25 , thus demonstrating that thiol
groups directly involve in oxidative modification of
NarK-ATPase.
Following this observations, we have compared in
 .further experiments the effect of DNIC-CYS 1:2
complex on both enzymatic activity and DTNB ac-
cessible SH-groups of kidney enzyme. As it is seen in
Fig. 5, both enzyme activity and SH-groups content
are suppressed simultaneously with time of preincu-
bation. 50%-inhibition of the activity corresponds to
50%-disappearance of DTNB accessible thiols Fig.
.5 .
Inhibition of NarK-ATPase by the compounds
tested suggests to be irreversible one, because en-
zyme activity is not restored by 40 times dilution of
the sample after preincubation. The same conclusion
was reached in experiments with oxidative attack on
NarK-ATPase carried out by hypochlorous anion or
w x flhydrogen peroxide 22 . In the case of NO com-
plexes, however, enzyme activity suppressed by
DNIC-CYS can be restored by SH-containing com-
 .pounds like cysteine or dithiotreitol DTT . Fifteen
min incubation of kidney enzyme with diamagnetic
form of DNIC-CYS suppresses the activity by 40%
and successive 10 min incubation of the sample with
 .1 mM cysteine 258C results in complete restoration
 .of the activity Table 2 . Use of 100 mM DTT under
the same conditions recovers the activity by 94%. In
this last case, the total restoration of SH-groups of the
 .enzyme was also demonstrated Table 3 .
3.4. Substrate dependence
Substrate dependence of the enzyme is described
w xby a complex curve with intermediary plateau 26 .
This feature presumably reflects the interprotomer
interaction within oligomeric complexes of the mem-
brane bound enzyme, at least solubilization of the
enzyme by non-ionic detergent being not followed
.by a suppression of enzyme activity decreases the
molecular size of NarK-ATPase close to its pro-
tomeric form with a subsequent transformation of the
substrate dependence curve into one that is hyper-
w xbolic 27 . We have demonstrated recently that oxida-
tive modification of NarK-ATPase being accompa-
Table 2
 .Effect of DNIC-CYS on kidney NarK-ATPase from three experiments
 .  .Conditions Enzyme activity mean"S.D. Enzyme activity mean"S.D.
 .  .mmol P rmg per h, 258C : with no additions mmol P rmg per h, 258C : with 1 mM cysteinei i
Control 211"12 240"17
 .50 mM DNIC-CYS 1:2 125"8 245"15
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Table 3
 .Effect of 50 mM DNIC-CYS 1:2 on NarK-ATPase activity and SH-group content in kidney enzyme preparation in the absence or
 .presence of 100 mM DTT from three experiments
Conditions NarK-ATPase Amount of SH-groups NarK-ATPase Amount of SH-groups
 .  .  .  .activity mean"S.D. mean"S.D. activity mean"S.D. mean"S.D.
  .   .mmol P rmg nmolrmg protein , mmol P rmg nmolrmg protein ,i i
. .per h at 258C ; without DTT per h at 258C ; with 100 mM DTT
without DTT with 100 mM DTT
Control 170"11 46"3 179"9 53"4
qDNIC-CYS 119"10 30"2 160"10 46"3
nied by attack to SH-groups of the protein, also
resulted in simplification of the substrate dependence
w xcurve 25 . In these experiments we have found the
same correlation — inhibition of the activity being
accompanied with decrease in amount of SH-groups
simultaneously resulted in transformation of the curve
with an intermediary plateau into that close to hyper-
 .bolic one Fig. 6 .
The substrate dependence curve for the native
enzyme consists of two components, a Michaelis
w xcurve and a Hill curve 25 each corresponding ap-
proximately half of the maximal activity V qmax M
.V s0.504q0.497s1.01 . The some substratemax H
dependence for the oxidazed enzyme 40 mM DNIC-
.Cys 1:2, 15 min at 48C is consisted of only first part
 .V which is equal to 0.525 arbitrary units. Thusmax M
the Hill component disappeared after oxidative modi-
fication with subsequent decrease in affinity of the
enzyme to ATP K increased from 0.075 mM tom
.  .0.816 mM Fig. 6 .
3.5. Modification of S-nitroso glutathione efficiency
Effect of mononitroso glutathione on the enzyme
was strongly increased when 36 mM FeSO and 724
mM cysteine were simultaneously added to 100 mM
GS-NO. In these experiments brain enzyme was
preincubated 15 min at 48C with either 100 mM
GS-NO or 100 mM GS-NOq36 mM FeSO q764
mM cysteine; then NarK-ATPase activity was tested.
In the former case only 11% inhibition was observed,
while in the latter one the enzyme was inhibited by
Fig. 6. Dependence of dog kidney NarK-ATPase on ATP concentration. A: native enzyme; B: sample of enzyme after 30 min
 .  .preincubation with 42 mM DNIC-CYS 1:2 . NarK-ATPase 130 mgrml was treated with DNIC-CYS as described in Fig. 1. Activity
 .was measured at 378C in medium containing 0.03–3 mM ATP, 5 mM MgCl , 130 mM NaCl, 20 mM KCl, 30 mM PIPES pH 7.4 and2
expressed in arbitrary units.
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about 70%. We suggest that in excess of ferrous ions
and cysteine, some portion of GS-NO fl was trans-
formed into diamagnetic DNIC-CYS complex. Such
transformation was recently demonstrated in model
experiments when FeSO and cysteine were added to4
w xS-nitrosothiol solution 14,28 .
Actually, simultaneous addition of 36 mM Fe2q
and 72 mM cysteine to 100 mM GS-NO resulted in
the decomposition of GS-NO and formation of dia-
magnetic DNIC-GS in concentrations corresponding
to the amount of NO fl released and ferrous ions
 .accessible no more than 36 mM . We have measured
the amount of GS-NO breaking down under these
conditions, using its characteristic absorbtion spec-
 .trum band at 338 nm and calculated that under
conditions used, 70–80% of GS-NO is dissipated. As
a result of interaction of NO fl formed with 36 mM
FeSO and 72 mM cysteine added, about 36 mM of4
diamagnetic DNIC-CYS has to be formed. Thus, the
mixture of low active GS-NO and highly active
DNIC-CYS was characterised by increased inhibitory
activity than GS-NO alone.
 .Contrary to these data, paramagnetic DNIC 1:30
complex has no inhibiting effect on NarK-ATPase
 .activity but even slightly by 12–15% activated the
enzyme. The results presented suggest that transfor-
mation of the NO-thiol derivatives in the cell can
exert diverse effects on SH-containing proteins de-
pending on environmental concentration of low-
molecular weight thiols.
4. Discussion
It was demonstrated in the literature that NarK-
ATPase of different tissues can be regulated by pro-
w xtein kinases 29,30 . On the other side, cellular effects
of NO fl is known to be result in cGMP formation and
w xprotein kinase C activation 7,31 . In our enzyme
preparations, however this way of regulation can not
be realyzed because of lack of protein kinase activi-
ties which was demonstrated by the absence of en-
zyme phosphorylation without addition of exogenous
 .protein kinases our unpublished observation . Thus,
effect of the compounds studied on NarK-ATPase
activity is presumably mediated by not the regulatory
phosphorylation as in the case of protein kinase but
modification of sulfhydryl groups of the enzyme by
nitroso compounds.
Of all the inhibitors used the most effective in
modification of NarK-ATPase were diamagnetic
DNIC containing thiol ligands glutathione or cys-
teine, the latter possessing the highest efficiency. The
following mechanism of their action can be proposed
q q.consisting of transfer of Fe NO from the com-2
plex used onto thiol groups of the protein. This
blocks participation of the groups modified in cat-
alytic processes andror interprotomer interactions.
This possibility is illustrated by an interaction of
 .bovine serum albumin and DNIC 1:2 with low-
w xmolecular thiol containing ligands 28 . The reaction
q q.was expressed in a quantitative transfer of Fe NO 2
group from DNIC to the protein. Further addition to
this mixture of low-molecular weight thiols, namely
cysteine, in excess, resulted in dissociation of the
complex formed. Under high concentration of cys-
teine a reversal process took place — transfer of
q q.Fe NO onto cysteine. It is likely that a similar2
processes took place when restoration of NarK-
ATPase activity inhibited by diamagnetic highly ac-
tive DNIC-CYS was demonstrated after addition of
 .cysteine or DTT to reaction mixture Tables 2 and 3 .
The common mechanism of NarK-ATPase inhibition
by DNIC is suggested to be described by following
reaction:
GS-NO is much less effective as inhibitor of
NarK-ATPase than DNIC. In agreement with pre-
sent days understanding, interaction of the S-nitrosyl
group with proteins results in S-trans-nitrosylation,
e.g., transfer of NOq group from S-nitroso thiols to
SH-groups of protein. However the low effect of
GS-NO on NarK-ATPase and the increase of the
inhibitory action after transformation of GS-NO into
DNIC suggests that more reliable mechanism of SH-
groups inactivation includes the above reaction.
It is well known that Fe ions and S-nitroso thiols
easily form thiol-containing DNIC in the presence of
w xcysteine 14,28 . In agreement with data presented,
formation of the dimeric DNIC complex will inhibit
SH-containing proteins more efficiently than in the
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case of S-nitroso thiols. Transformation of S-nitroso
thiols into DNIC was demonstrated in living cells
w x  .28,32 . This attracts an attention to mechanism s of
regulation of SH-containing proteins like K-channels,
NMDA receptors or NarK-ATPase by nitroso com-
pounds in vivo.
w xAs we noted, Sato et al. 8 have demonstrated
inhibition of commertially available NarK-ATPase
from cerebral cortex by a number of NO fl generating
drugs. The inhibiting action of these drugs but not of
.SNP was eliminated by reduced glutathione, DTT
and superoxide dismutase, the last being used as NO fl
scavenger. The inhibiting effect of SNP was acceler-
ated by DTT. The conclusion was that NO-derived
products may attack SH-groups of the enzyme to
w xinduce their oxidation 8 . Our data directly demon-
strate this possibility. The inhibiting effect of NO fl on
membrane bound NarK-ATPase in our experiments
is realised by formation of nitroso compounds which
attack protein SH-groups resulting in suppression of
the activity.
At first sight, a recent publication of Gupta et al.
w x33 is in contradiction with these conclusion. Gupta
et al. have found that SNP or GS-NO possesses a
dose-dependent activating action on 86Rbq uptake
and relaxation of smooth muscle. This effect was not
mimicked by 8-bromocyclic GMP evidencing that it
was realized not via guanilate cyclase, but was sup-
pressed by ouabain and methylene blue. The authors
concluded that the NO radical can activate not in-
.hibit NarK-ATPase, thus stimulating relaxation of
w xsmooth muscle cells 33 .
Among several explanations of these data obtained
on such complex system as the whole muscle, the
likelyhood of the direct NO fl effect on NarK-ATPase
is the less possible one. NarK-ATPase of smooth
muscle membranes is presented by the same isoforms
w xas brain enzyme 24 , which, as we demonstrated is
not sensitive to direct addition of SNP. More likely,
the reason for activation of the ouabain dependent
86Rbq uptake by NO fl lies in activation of antioxi-
dant defense of the cells which was recently demon-
w xstrated 2 . This effect could supposingly result in
mobilization of cell thiols protecting SH-containing
proteins. This opportunity reflecting indirect effects
of NO fl other than that directed toward protein kinase
system can be realyzed in the whole muscle. Addi-
tional regulatory way consisting in the inhibiting
effect of NO fl on NarK-ATPase was described here
which is realyzed via formation of dinitrosyl com-
plexes and their attack of SH groups of protein.
Thus, interpretation of multiple effects of S-nitroso
thiols in biological systems has to be due regard to
 .their secondary effects namely, DNIC formation .
The study presented here leads to the conclusion that
NarK-ATPase, the key enzyme regulating asymmet-
ric distribution of monovalent ions across outer cell
membranes, could be regulated in situ by nitroso
thiols but not by the NO fl radical alone. The further
step of our study has to be demonstration of the
effect of these compounds on NarK-ATPase in intact
tissue.
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